Paclitaxel ( DrugBank: Paclitaxel )

2 diseases

告示番号	疾患名（ページ内リンク）	臨床試験数
46	悪性関節リウマチ	1
85	特発性間質性肺炎	8

46. 悪性関節リウマチ

臨床試験数 : 4,356 / 薬物数 : 2,567 - (DrugBank : 415) / 標的遺伝子数 : 192 - 標的パスウェイ数 : 228

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00055133 (ClinicalTrials.gov)	September 2002	19/2/2003	A Study Using Intravenous Paxceed™ to Treat Patients With Rheumatoid Arthritis	A Phase 2 Open-Label Clinical Study Using Intravenous Paxceed™ to Treat Patients With Rheumatoid Art ...	Rheumatoid Arthritis	Drug: Micellar Paclitaxel for Injection	Angiotech Pharmaceuticals	NULL	Completed	21 Years	70 Years	Both	50	Phase 2	United States

First Previous1Next Last

85. 特発性間質性肺炎

臨床試験数 : 627 / 薬物数 : 443 - (DrugBank : 120) / 標的遺伝子数 : 99 - 標的パスウェイ数 : 212

diseases per page:

Showing 1 to 8 of 8 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	JPRN-jRCTs071180049	23/05/2017	15/03/2019	Japanese Intergroup Study of Nintedanib for NSCLC with IPF	A randomized phase III study of carboplatin plus nab-paclitaxelwith or without nintedanib for advanc ...	Advanced Non-small cell lung cancer with idiopathic pulmonary fibrosis	carboplatin + nab-paclitaxel carboplatin + nab-paclitaxel + nintedanib	Okamoto Isamu	Otsubo Kohei	Complete	>= 20age old	Not applicable	Both	240	Phase 3	Japan
2	JPRN-UMIN000026799	2017/05/12	01/04/2017	A randomized phse 3 study of carboplatin plus nab-paclitaxelwith or without nintedanib for advanced ...	A randomized phse 3 study of carboplatin plus nab-paclitaxelwith or without nintedanib for advanced ...	Non-small-cell lung cancer with idiopathic pulmonary fibrosis	A: 4 cycles of Carboplatin (AUC 6, day 1) plus nab-Paclitaxel(100 mg/m2, day 1, 8, 15) repeated ever ...	Research Institute for Diseases of the Chest, Kyushu University	NULL	Complete: follow-up continuing	20years-old	Not applicable	Male and Female	240	Phase 3	Japan
3	JPRN-UMIN000021591	2016/04/04	01/04/2016	The pilot study of Nintedanib and Carboplatin plus Paclitaxelfor advanced non-small cell lung cancer ...	The pilot study of Nintedanib and Carboplatin plus Paclitaxelfor advanced non-small cell lung cancer ...	Advanced non-small cell lung cancer with idiopathic interstitial pneumonia	carboplatin AUC6 D1 paclitaxel 200mg/m D1 tryweekly 4cycle nintedanib 150mg twice daily	Hirosaki University Graduate School of Medicine	NULL	Complete: follow-up complete	20years-old	Not applicable	Male and Female	30	Not selected	Japan
4	JPRN-jRCTs051180149	24/01/2013	20/03/2019	CBDCA plus PTX for NSCLC (squamous) with IP	Phase II study of carboplatin plus weekly paclitaxelfor advanced squamous cell lung cancer with idio ...	Squamous cell lung cancer Lung cancer	Carboplatin (AUC=5) given on day1 and paclitaxel(70mg/m2) given on days 1,8,15 every 4weeks until di ...	Katakami Nobuyuki	NULL	Complete	>= 20age old	Not applicable	Both	40	Phase 2	Japan
5	JPRN-jRCTs061180046	17/01/2013	12/03/2019	CBDCA, PTX and BV for NSCLC (non-sq) with IP	Phase II study of carboplatin, weekly paclitaxeland bevacizumab for advanced non-squamous cell, non- ...	Non-squamous, non-small cell lung cancer Lung cancer	Carboplatin (AUC=5) given on day1, paclitaxel(70mg/m2) given on days 1,8,15 and bevacizumab (15mg/m2 ...	Katakami Nobuyuki	NULL	Complete	>= 20age old	Not applicable	Both	35	Phase 2	Japan
6	JPRN-UMIN000018248	2012/12/01	09/07/2015	Phase II study of carboplatin plus weekly paclitaxelfor advanced squamous cell lung cancer with idio ...	Phase II study of carboplatin plus weekly paclitaxelfor advanced squamous cell lung cancer with idio ...	advanced squamous cell lung cancer with idiopathic interstitial pneumonia	Carboplatin AUC = 5 , day1 Paclitaxel 70mg/m2, day1,8,15 4-6 cycle	IP lung cancer study group	NULL	Complete: follow-up complete	20years-old	Not applicable	Male and Female	40	Phase 2	Japan
7	JPRN-UMIN000018322	2012/12/01	15/07/2015	Phase II study of carboplatin, weekly paclitaxeland bevacizumab for advanced non-squamous cell, non- ...	Phase II study of carboplatin, weekly paclitaxeland bevacizumab for advanced non-squamous cell, non- ...	advanced non-squamous cell, non-small-cell lung cancer with idiopathic interstitial pneumonia	carboplatin AUC = 5, day1 paclitaxel70mg/m2, day1 ,8 ,15 bevacizumab 15mg/kg, day1 every 4 weeks, 4-6 c ...	IP lung cancer study group	NULL	Recruiting	20years-old	Not applicable	Male and Female	35	Phase 2	Japan
8	JPRN-UMIN000015929	2007/05/10	12/12/2014	Prospective observational study of Idiopathic pulmonary fibrosis with Non-small-cell lung cancer(LOG ...	Prospective observational study of Idiopathic pulmonary fibrosis with Non-small-cell lung cancer(LOG ...	Idiopathic pulmonary fibrosis	Carboplatin/paclitaxelcombination therapy (dosage and administration) Paclitaxel(PAC):175-200mg/m2 at ...	Lung Oncology Group in Kyushu, Japan (LOGIK)	NULL	Complete: follow-up complete	20years-old	75years-old	Male and Female	60	Not selected	Japan

First Previous1Next Last

先頭へ